Trevi Therapeutics, Inc. TRVI Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s investment proceeds?
- Trevi Therapeutics, Inc. (TRVI) reported investment proceeds of $25.55M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s investment proceeds changed year-over-year?
- Trevi Therapeutics, Inc.'s investment proceeds increased by 45.2% year-over-year, from $17.6M to $25.55M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s investment proceeds?
- Over 2 years (2023 to 2025), Trevi Therapeutics, Inc.'s investment proceeds has grown at a 5.0% compound annual growth rate (CAGR), from $69.5M to $76.57M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.